Jazz Pharmaceuticals PLC at Cantor Fitzgerald Global Healthcare Conference Transcript
Next presenting company. I'm Charles Duncan. I'm a Biotech Analyst with Cantor. And it's a pleasure to introduce Jazz Pharmaceuticals, who's going to present at the Cantor 2023 Global Healthcare Conference. Jazz Pharmaceuticals is a company I've known for a long time. But I only recently had an opportunity to take over coverage. And so it's an exciting time for this company that I've previously known as a neuro innovator, but it clearly has a very interesting oncology pipeline as well.
So it's a pleasure to introduce Bruce Cozadd the company's Chairman and CEO, Bruce. Nice to see you. Thanks for coming. Robert Iannone, the company's Global Head of R&D, Rob, nice to see you. And Kim Sablich, the company's EVP and GM. So sorry for the delay. I had to run upstairs and grab a tylenol, but with that, we'll have Bruce give us an overview on Jazz, and then I'll pepper him with a few questions. Bob?
Awesome. And Charles, thanks for the introduction. I'm glad to be here at
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |